Source: New feed
Puma Biotech Shares Are Roaring On An FDA Review. Here's What Could Still Go Wrong
The story of Puma Biotechnology has been one of the most dramatic in the drug business. Three years ago Puma's chief executive, Alan Auerbach, was a billionaire based on his holdings in the company. But now the company's shares are down 80% from ...
Puma Biotech Surges To 6-Month High On Likely Cancer Drug ApprovalInvestor's Business Daily
Puma Biotech stock surges 50% on favorable FDA release for breast cancer drugMarketWatch
Here's Why Wednesday Is The Next Big Catalyst For Puma BiotechBenzinga
Reuters -Motley Fool -StreetInsider.com
all 165 news articles »
Shares soar as 'breakthrough' news in biotech continues to run hot this week
The FDA has been working overtime this week handing out new breakthrough therapy designations for a whole slate of biotech drugs in the clinic. But five years after the program was launched, investors are still ready to cheer on each announcement with ...